Currently, Amphastar Pharmaceuticals Inc [AMPH] is trading at $22.63, up 6.00%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AMPH shares have gain 6.39% over the last week, with a monthly amount drifted -8.31%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] stock has seen the most recent analyst activity on May 12, 2025, when JP Morgan downgraded its rating to a Neutral but kept the price target unchanged to $30 for it. Previously, Piper Sandler downgraded its rating to Neutral on February 04, 2025, and dropped its price target to $36. On November 22, 2024, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $55 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $60 on March 05, 2024. BofA Securities initiated its recommendation with a Neutral and recommended $63 as its price target on November 17, 2023.
This stock has fluctuated between a low of $20.43 and a high of $53.96 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] shares were valued at $22.63 at the most recent close of the market. An investor can expect a potential return of 41.41% based on the average AMPH price forecast.
Analyzing the AMPH fundamentals
Trailing Twelve Months sales for Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] were 730.66M which represents -0.76% decline. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.19 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.86 points at the first support level, and at 21.09 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.05, and for the 2nd resistance point, it is at 23.47.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] is 2.95. In addition, the Quick Ratio stands at 2.02 and the Cash Ratio stands at 0.92. Considering the valuation of this stock, the price to sales ratio is 1.46, the price to book ratio is 1.44 and price to earnings (TTM) ratio is 8.21.
Transactions by insiders
Recent insider trading involved Petersen Floyd F., Director, that happened on Jul 02 ’25 when 500.0 shares were sold. Director, Petersen Floyd F. completed a deal on Jul 02 ’25 to buy 500.0 shares. Meanwhile, Director Petersen Floyd F. sold 500.0 shares on Jun 02 ’25.
